Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown
- PMID: 28070599
- PMCID: PMC5502199
- DOI: 10.1007/s00204-016-1926-1
Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown
Abstract
Amyotrophic lateral sclerosis (ALS) is the most common adult-onset paralytic disorder. It is characterized by progressive degeneration of the motor neurons controlling voluntary movement. The underlying mechanisms remain elusive, a fact that has precluded development of effective treatments. ALS presents as a sporadic condition 90-95% of the time, i.e., without familial history or obvious genetic mutation. This suggests that ALS has a strong environmental component. Organophosphates (OPs) are prime candidate neurotoxicants in the etiology of ALS, as exposure to OPs was linked to higher ALS incidence among farmers, soccer players, and Gulf War veterans. In addition, polymorphisms in paraoxonase 1, an enzyme that detoxifies OPs, may increase individual vulnerability both to OP poisoning and to the risk of developing ALS. Furthermore, exposure to high doses of OPs can give rise to OP-induced delayed neuropathy (OPIDN), a debilitating condition akin to ALS characterized by similar motor impairment and paralysis. The question we pose in this review is: "what can we learn from acute exposure to high doses of neurotoxicants (OPIDN) that could help our understanding of chronic diseases resulting from potentially decades of silent exposure (ALS)?" The resemblances between OPIDN and ALS are striking at the clinical, etiological, neuropathological, cellular, and potentially molecular levels. Here, we critically present available evidence, discuss current limitations, and posit future research. In the search for the environmental origin of ALS, OPIDN offers an exciting trail to follow, which can hopefully lead to the development of novel strategies to prevent and cure these dreadful disorders.
Keywords: Amyotrophic lateral sclerosis; Delayed neuropathy; Motor neuron; Neurodegeneration; Neurotoxicity; Organophosphate.
Figures
Comment in
-
Commentary to Merwin SJ, Obis T, Nunez Y, Re DB (2017) Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown. Arch Toxicol [Epub ahead of print]. doi:10.1007/s00204-016-1926-1.Arch Toxicol. 2017 Sep;91(9):3189-3190. doi: 10.1007/s00204-017-1992-z. Epub 2017 May 24. Arch Toxicol. 2017. PMID: 28540406 No abstract available.
-
Reply to the Commentary by Lotti M. and Moretto A. "Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown and the unknown.Arch Toxicol. 2017 Sep;91(9):3191-3193. doi: 10.1007/s00204-017-2025-7. Epub 2017 Jul 12. Arch Toxicol. 2017. PMID: 28702692 No abstract available.
References
-
- Abdel-Rahman A, Shetty AK, Abou-Donia MB. Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: dose-response relationships. Neuroscience. 2002;113:721–41. - PubMed
-
- Abou-Donia MB. Organophosphate ester-induced chronic neurotoxicity (OPICN). In: Winder C, editor. Contaminated Air Protection Conference, Proceedings of a Conference, held at Imperial College; London. 20–21 April; Sydney: University of New South Wales; 2005. pp. 59–90.
-
- Abou-Donia MB. Organophosphorus ester-induced chronic neurotoxicity. Arch Environ Health. 2003;58:484–97. - PubMed
-
- Abou-Donia MB. Triphenyl phosphite: A type II organophosphorus compound-induced delayed neurotoxic agent. In: Chamber JELP, editor. Organophosphates Chemistry, Fate, and Effects. Part IV: Toxic Effects-Organismal. Academic Press; San Diego: 1992. pp. 327–51.
-
- Abou-Donia MB, Lapadula DM. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: type I and type II. Annu Rev Pharmacol Toxicol. 1990;30:405–40. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
